153 related articles for article (PubMed ID: 22778155)
1. Fibroblast growth factor receptor 2 IIIc as a therapeutic target for colorectal cancer cells.
Matsuda Y; Hagio M; Seya T; Ishiwata T
Mol Cancer Ther; 2012 Sep; 11(9):2010-20. PubMed ID: 22778155
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies to fibroblast growth factor receptor 2 effectively inhibit growth of gastric tumor xenografts.
Zhao WM; Wang L; Park H; Chhim S; Tanphanich M; Yashiro M; Kim KJ
Clin Cancer Res; 2010 Dec; 16(23):5750-8. PubMed ID: 20670946
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of fibroblast growth factor receptor 2 attenuates proliferation and invasion of pancreatic cancer.
Matsuda Y; Yoshimura H; Suzuki T; Uchida E; Naito Z; Ishiwata T
Cancer Sci; 2014 Sep; 105(9):1212-9. PubMed ID: 24975163
[TBL] [Abstract][Full Text] [Related]
4. Overexpressed fibroblast growth factor receptor 2 in the invasive front of colorectal cancer: a potential therapeutic target in colorectal cancer.
Matsuda Y; Ishiwata T; Yamahatsu K; Kawahara K; Hagio M; Peng WX; Yamamoto T; Nakazawa N; Seya T; Ohaki Y; Naito Z
Cancer Lett; 2011 Oct; 309(2):209-19. PubMed ID: 21745712
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of fibroblast growth factor receptor 2 isoform IIIc: relevance to endometrioid adenocarcinoma carcinogenesis and histological differentiation.
Peng WX; Kudo M; Fujii T; Teduka K; Naito Z
Int J Clin Exp Pathol; 2014; 7(3):1069-76. PubMed ID: 24696723
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of fibroblast growth factor receptor 2 IIIc promotes human pancreatic cancer cell proliferation.
Ishiwata T; Matsuda Y; Yamamoto T; Uchida E; Korc M; Naito Z
Am J Pathol; 2012 May; 180(5):1928-41. PubMed ID: 22440254
[TBL] [Abstract][Full Text] [Related]
7. Clinical difference between fibroblast growth factor receptor 2 subclass, type IIIb and type IIIc, in gastric cancer.
Yashiro M; Kuroda K; Masuda G; Okuno T; Miki Y; Yamamoto Y; Sera T; Sugimoto A; Kushiyama S; Nishimura S; Togano S; Ohira M
Sci Rep; 2021 Feb; 11(1):4698. PubMed ID: 33633310
[TBL] [Abstract][Full Text] [Related]
8. Binding of human recombinant mutant soluble ectodomain of FGFR2IIIc to c subtype of FGFRs: implications for anticancer activity.
Liu Z; Liu G; Zhang GL; Li J; He YQ; Zhang SS; Wang Y; He WY; Cheng GH; Yang X; Xu J; Wang J
Oncotarget; 2016 Oct; 7(42):68473-68488. PubMed ID: 28049184
[TBL] [Abstract][Full Text] [Related]
9. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
10. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells.
Ruohola JK; Viitanen TP; Valve EM; Seppänen JA; Loponen NT; Keskitalo JJ; Lakkakorpi PT; Härkönen PL
Cancer Res; 2001 May; 61(10):4229-37. PubMed ID: 11358849
[TBL] [Abstract][Full Text] [Related]
11. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
12. Expression of the ets-1 proto-oncogene in human colorectal carcinoma.
Nakayama T; Ito M; Ohtsuru A; Naito S; Sekine I
Mod Pathol; 2001 May; 14(5):415-22. PubMed ID: 11353051
[TBL] [Abstract][Full Text] [Related]
13. Fgfr1 and the IIIc isoform of Fgfr2 play critical roles in the metanephric mesenchyme mediating early inductive events in kidney development.
Sims-Lucas S; Cusack B; Baust J; Eswarakumar VP; Masatoshi H; Takeuchi A; Bates CM
Dev Dyn; 2011 Jan; 240(1):240-9. PubMed ID: 21128305
[TBL] [Abstract][Full Text] [Related]
14. The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas.
Zheng HC; Xia P; Xu XY; Takahashi H; Takano Y
Hum Pathol; 2011 Mar; 42(3):424-33. PubMed ID: 21193223
[TBL] [Abstract][Full Text] [Related]
15. Discovery and Characterization of a High-Affinity Small Peptide Ligand, H1, Targeting FGFR2IIIc for Skin Wound Healing.
Zhao Y; Wang Q; Jin Y; Li Y; Nie C; Huang P; Li Z; Zhang B; Su Z; Hong A; Chen X
Cell Physiol Biochem; 2018; 49(3):1033-1048. PubMed ID: 30196288
[TBL] [Abstract][Full Text] [Related]
16. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
[TBL] [Abstract][Full Text] [Related]
17. Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases.
Ueda J; Matsuda Y; Yamahatsu K; Uchida E; Naito Z; Korc M; Ishiwata T
Oncogene; 2014 Sep; 33(36):4485-95. PubMed ID: 24077287
[TBL] [Abstract][Full Text] [Related]
18. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
Ding C; Li L; Yang T; Fan X; Wu G
BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
[TBL] [Abstract][Full Text] [Related]
19. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
[TBL] [Abstract][Full Text] [Related]
20. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
